1.Influenza Vaccination and Associated Factors among Korean Cancer Survivors : A Cross-Sectional Analysis of the Fourth & Fifth Korea National Health and Nutrition Examination Surveys.
Kyung Hyun CHOI ; Sang Min PARK ; Kiheon LEE ; Ju Hyun LEE ; Joo Sung PARK
Journal of Korean Medical Science 2014;29(8):1061-1068
Influenza vaccination is important for cancer survivors, a population with impaired immunity. This study was designed to assess influenza vaccination patterns among Korean cancer survivors. In this cross-sectional analysis, data were obtained from standardized questionnaires from 943 cancer survivors and 41,233 non-cancer survivors who participated in the Fourth and Fifth Korea National Health and Nutrition Examination Surveys (2007-2011). We identified the adjusted influenza vaccination rates and assessed factors associated with influenza vaccination using multivariate logistic regression. Cancer survivors tended to have a higher adjusted influenza vaccination rate than the general population. The rates for influenza vaccination in specific cancer types such as stomach, hepatic, colon, and lung cancers were significantly higher than non-cancer survivors. Among all cancer survivors, those with chronic diseases, elderly subjects, and rural dwellers were more likely to receive influenza vaccination; those with cervical cancer were less likely to receive influenza vaccination. Cancer survivors were more likely to receive influenza vaccinations than non-cancer survivors, but this was not true for particular groups, especially younger cancer survivors. Cancer survivors represent a sharply growing population; therefore, immunization against influenza among cancer survivors should be concerned as their significant preventative healthcare services.
Adult
;
Age Distribution
;
Aged
;
Aged, 80 and over
;
Comorbidity
;
Disease Susceptibility/mortality
;
Educational Status
;
Female
;
Health Behavior
;
Humans
;
Influenza Vaccines/*therapeutic use
;
Influenza, Human/*mortality/*prevention & control
;
Male
;
Mass Vaccination/*utilization
;
Middle Aged
;
Neoplasms/*mortality
;
Republic of Korea/epidemiology
;
Risk Factors
;
Sex Distribution
;
Social Class
;
Survival Rate
;
Survivors/*statistics & numerical data
2.Implication of reported viral hepatitis incidence rate change in Hubei Province, China, between 2004-2010.
Ying HU ; Chuanhua YU ; Banghua CHEN ; Lei WANG
Journal of Huazhong University of Science and Technology (Medical Sciences) 2012;32(3):428-433
This study examined the change of reported incidence rate for viral hepatitis in Hubei province, China, between 2004 to 2010 to provide scientific evidence for viral hepatitis control. Reported viral hepatitis infection cases were queried from Centre for Disease Control of Hubei Province, China. The incidence of viral hepatitis A decreased steadily across the study period. Viral hepatitis B composed 85% of the viral hepatitis cases. When reported incidence rates for chronic hepatitis B increased, the rates of acute and unclassified cases dropped from 2005 to 2010. The reported viral hepatitis B incidence rate for males was around 1.5-2 times higher than for females. The average annual percentage change of reported viral hepatitis B incidence rates was 4%. The same index for viral hepatitis C was 28%. The reported viral hepatitis B incidence rate of people under 20 years old declined over the period. This decrease was mainly attributed to the recent implementation of vaccination plan. Reported incidence rate of viral hepatitis E also rose in those years. Having a better understanding on reported incidence rates of the present surveillance system is important for developing strategies for further prevention of viral hepatitis. In addition, the data showed that a surveillance system that differentiates new and former infected cases will be more effective in providing evidence for disease control.
Adolescent
;
Adult
;
Age Distribution
;
Aged
;
Aged, 80 and over
;
Child
;
Child, Preschool
;
China
;
epidemiology
;
Female
;
Hepatitis, Viral, Human
;
epidemiology
;
prevention & control
;
Humans
;
Incidence
;
Infant
;
Infant, Newborn
;
Male
;
Mass Vaccination
;
trends
;
utilization
;
Middle Aged
;
Risk Factors
;
Sex Distribution
;
Viral Hepatitis Vaccines
;
therapeutic use
;
Young Adult